Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
(NASDAQ: RLMD) Delayed: 6.92 +0.03 (0.44%)
Previous Close $6.89    52 Week High $4.10 
Open $6.74    52 Week Low $0.87 
Day High $7.02    P/E N/A 
Day Low $6.66    EPS $0.00 
Volume 287,996